Last reviewed · How we verify
ethinyl estradiol 30 micrograms, gestodene 75 micrograms
ethinyl estradiol 30 micrograms, gestodene 75 micrograms is a Small molecule drug developed by Prince of Songkla University. It is currently FDA-approved. Also known as: Gynera.
At a glance
| Generic name | ethinyl estradiol 30 micrograms, gestodene 75 micrograms |
|---|---|
| Also known as | Gynera |
| Sponsor | Prince of Songkla University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ethinyl estradiol 30 micrograms, gestodene 75 micrograms CI brief — competitive landscape report
- ethinyl estradiol 30 micrograms, gestodene 75 micrograms updates RSS · CI watch RSS
- Prince of Songkla University portfolio CI
Frequently asked questions about ethinyl estradiol 30 micrograms, gestodene 75 micrograms
What is ethinyl estradiol 30 micrograms, gestodene 75 micrograms?
ethinyl estradiol 30 micrograms, gestodene 75 micrograms is a Small molecule drug developed by Prince of Songkla University.
Who makes ethinyl estradiol 30 micrograms, gestodene 75 micrograms?
ethinyl estradiol 30 micrograms, gestodene 75 micrograms is developed and marketed by Prince of Songkla University (see full Prince of Songkla University pipeline at /company/prince-of-songkla-university).
Is ethinyl estradiol 30 micrograms, gestodene 75 micrograms also known as anything else?
ethinyl estradiol 30 micrograms, gestodene 75 micrograms is also known as Gynera.
What development phase is ethinyl estradiol 30 micrograms, gestodene 75 micrograms in?
ethinyl estradiol 30 micrograms, gestodene 75 micrograms is FDA-approved (marketed).
Related
- Manufacturer: Prince of Songkla University — full pipeline
- Also known as: Gynera